Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Archive
    • Upcoming Scientific Articles
  • Info for
    • Authors
    • Reviewers
    • Advertisers
    • Subscribers
  • About Us
    • About the North Carolina Medical Journal
    • Editorial Board
  • More
    • Alerts
    • Feedback
    • Help
    • RSS
  • Other Publications
    • North Carolina Medical Journal

User menu

  • My alerts
  • Log in

Search

  • Advanced search
North Carolina Medical Journal
  • Other Publications
    • North Carolina Medical Journal
  • My alerts
  • Log in
North Carolina Medical Journal

Advanced Search

  • Home
  • Content
    • Current
    • Archive
    • Upcoming Scientific Articles
  • Info for
    • Authors
    • Reviewers
    • Advertisers
    • Subscribers
  • About Us
    • About the North Carolina Medical Journal
    • Editorial Board
  • More
    • Alerts
    • Feedback
    • Help
    • RSS
  • Follow ncmj on Twitter
  • Visit ncmj on Facebook
Research ArticlePolicy Forum

Screening for Diabetic Retinopathy

Strategies for Improving Patient Follow-up

Julie B. Skaggs, Xinxin Zhang, Daniel J. Olson, Seema Garg and Richard M. Davis
North Carolina Medical Journal March 2017, 78 (2) 121-123; DOI: https://doi.org/10.18043/ncm.78.2.121
Julie B. Skaggs
fellow, Department of Ophthalmology, UNC School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xinxin Zhang
student, UNC School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel J. Olson
student, UW Medicine, University of Washington, Seattle, Washington
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Seema Garg
associate professor, Department of Ophthalmology, UNC School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard M. Davis
associate professor, Department of Ophthalmology, UNC School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: richdavis@unc.edu
  • Article
  • References
  • Info & Metrics
  • PDF
Loading

Abstract

Diabetic retinopathy is a leading cause of preventable blindness. Timely screening and treatment prevent morbidity, though low follow-up rates remain problematic. Feasible and efficacious methods for increasing screening follow-up rates include patient education, a streamlined referral and scheduling process, and collaboration with local ophthalmologists and primary care providers.

In the US, 29 million people (9.3% of population) have diabetes, and over a million adults in North Carolina (about 10% of population) have diabetes [1]. Diabetes and its associated morbidities pose a significant health risk for the individual patient and a large burden for our already burgeoning health care system. Diabetic retinopathy is the leading cause of new cases of blindness in the US and the most common cause of blindness in North Carolina. With timely laser treatment and intravitreal anti-vascular endothelial growth factor (VEGF) therapy, severe vision loss from diabetic retinopathy can be reduced by 90% [2-4]. However, because early diabetic retinopathy is usually asymptomatic, the only avenue for patients to present in a timely fashion is through early screening.

Background

Diabetic retinopathy screening meets the World Health Organization criteria for screening programs, which stipulates the following: the condition must have not only a recognizable early or latent stage but also effective and well-accepted treatment options, and the condition must currently be (and be expected to remain) an important public health concern [5]. Of course, efforts to increase patient screening for diabetic retinopathy should accompany efforts to increase patient education regarding the disease. Although significant effort is being made to screen for and educate people about diabetic retinopathy, a recent national survey showed that 73% of adults aged 40 and over with diabetic retinopathy were unaware of their condition [6]. This was particularly prevalent in patients with less severe diabetic retinopathy, shorter diabetes duration, and lack of a recent eye examination [6].

Current Guidelines

Current diabetic retinopathy screening guidelines recommend a retinal examination in type 1 diabetics 5 years after diagnosis and at least annually thereafter. Type 2 diabetes patients should be examined immediately at the time of diagnosis and at least annually thereafter. More frequent examinations are advised for patients with progressing retinopathy. Gestational diabetes patients are not at risk of developing diabetic retinopathy and do not require eye examinations, whereas diabetes patients who become pregnant are at increased risk for progression of retinopathy and should receive eye examinations in the first trimester and at 1 year postpartum [7]. The retinal examination is usually conducted by an ophthalmologist or optometrist who looks through a dilated pupil using the indirect or direct ophthalmoscope or slit lamp biomicroscopy [7]. Recently, fundus photography telemedicine has become an alternative method for obtaining the retinal examination [8]. This method involves a trained photographer taking retinal images and sending them to a remote trained reader (typically an ophthalmologist or optometrist) for interpretation. Fundus photography telemedicine has been shown to have acceptable sensitivity and specificity for screening of diabetic retinopathy compared to in-person screens. It is also cost-effective and generally well-liked by patients [9, 10].

Disparities

Disparities in screening rates exist between ethnic, socioeconomic, and geographical groups nationally and in North Carolina. A North Carolina survey of people with diabetes showed that approximately 70% of non-Hispanic whites and African Americans received eye examinations in the year before the survey, compared to 61% of Native Americans and 52% of Hispanics [1]. This is consistent with national data showing that minorities tend to have lower rates of screening [10]. Screening rates also vary by geographic location, with rural populations having lower rates of screening, likely due to issues with access to care [11]. Diabetes patients with retinopathy who have access to reti-nopathy screening at or near the office of their primary care provider may more likely be screened out of convenience compared with those who are referred to an eye care specialist [12]. Other potential barriers to screening include financial difficulties and language differences [13].

Focus for Research

Improving screening rates for diabetic retinopathy has been a focus of research. Recommended interventions utilized by different communities include increasing patient and provider awareness, collaborating with community-based programs and disciplines, using electronic medical records and automatic reminders, utilizing mobile diabetes clinics, and providing services in multiple languages [13]. The University of North Carolina's management of diabetes patients is a current example of a health care system utilizing electronic medical records, automatic reminders, and interdisciplinary collaboration. In UNC's system, all diabetes patients are automatically reminded to schedule an annual eye examination. System alerts let primary care providers know when eye examinations are due and when they have been completed, giving them the opportunity to remind and counsel patients.

Patient Retention and Education

In many locations around North Carolina, diabetes patients are being seen for initial eye examinations; retaining these patients for their follow-up is a bigger challenge. This difficulty in following up with patients is not just a local phenomenon; in a recent study by Keenum et al published in JAMA Ophthalmology, based largely on an African American population in an urban setting, less than 30% of the study participants adhered to their recommended follow-up ophthalmic examinations [14]. These patients had access to a health care center housing both ophthalmology and primary care physicians in the same building that welcomed patients, including those without insurance [14]. Patients with higher rates of follow-up in the study were older and had knowledge of their hemoglobin A1C level, but tended not to accept assistance with setting up their follow-up ophthalmic examination appointments [14]. The fact that this study minimized many barriers to follow-up and provided assistance with scheduling follow-up, yet displayed a dismally low follow-up rate of 30% [14], suggests that patients experience additional barriers to care and that more research is needed to elucidate factors involved in low follow-up rates.

Some studies have shown that follow-up rates increase most with education. A randomized, controlled study in 1999 showed that intensive education to an intervention group increased follow-up appointment rates to about 54%, from about 27% [15]. The study's intensive education intervention group received a 9 page color book aimed at 3rd grade reading called The World is a Beautiful Place to See, a motivational video tape, and a semi-structured telephone call with counseling, all within a few weeks of the patient's first visit. Control patients, on the other hand, received nothing until 6 months after their first visit when they were mailed an American Diabetes Association meal planning booklet accompanied by a letter urging them to schedule a follow-up appointment [15].

In addition to more education, some studies show that telehealth efforts, especially those including an ongoing remote relationship with non-physician providers such as dietitians, nurse certified diabetes educators, and certified health educators, improve diabetes self-management [16]. Studies of this collaborative telehealth effort demonstrated improved hemoglobin A1C levels and better adherence to ocular examination follow-up [17].

Current Research

Currently Dr. Seema Garg, a retinal specialist at the University of North Carolina, is at the helm of a multicenter study to evaluate the effectiveness of telemedicine on diabetic retinopathy screening rates at busy primary care practices. So far in her study, retinal photographs using a non-mydriatic (no pupil dilation) retinal camera have been obtained for over 1700 patients in 5 sites spanning North Carolina. These images have been securely transferred to her over the internet, and she interprets them for the presence and severity of diabetic retinopathy. Thus far, more than half of the patients have attended these follow-up appointments at their primary care medical homes. The rate of follow up in her study is significantly higher than that of other studies. She postulates the reasons for this are manifold. First, patient education, as in other studies mentioned above, is a significant part of her study's program. The retinal telescreening in and of itself facilitates patient education regarding diabetes and its ocular effects. Also, English and Spanish educational materials from the National Eye Institute have been provided to each primary care clinic to raise patient awareness of retinal screening's importance for reducing diabetes complications. Second, collaboration with local ophthalmologists prior to the onset of the project made them aware that patients would be referred from the telemedicine network if they needed treatment or if their images were not clear enough to grade. Third, assistance by clinic staff in scheduling appointments for patients requiring a referral to an ophthalmologist may have encouraged patients to keep these appointments.

The high retention rate achieved by Dr. Garg supports a multidimensional approach that synthesizes telescreening with primary care collaboration and patient education. A similar approach that included an annual retinal assessment was used in a previous successful multidisciplinary telescreening effort by Davis et al [17]. Participants were randomized to receive either routine care or Diabetes TeleCare, a 12-month remote telehealth diabetes self-management program administered by dietitians and certified diabetes educators [17]. The Diabetes Telecare group, compared with the routine care group, was shown to have lower glycated hemoglobin and lipids at the 12 and 24 month marks. A higher portion of the Diabetes Telecare group (81.2%) also underwent eye exams compared to the routine care group (38.8%) [17]. Retinal telescreening in collaboration with patients' primary care providers is a promising new avenue for increasing rates of follow-up and compliance with diabetic retinopathy screening.

Conclusion

Diabetic retinopathy is a leading cause of preventable blindness and requires timely screening and treatment. Racial, socioeconomic, and geographic disparities in screening rates and follow-ups still exist. Efforts to decrease barriers including utilization of electronic medical records, system alerts, educational programs, language services, and combination of primary care and ophthalmology services into single facilities have improved screening rates and follow-up. Telehealth has also shown great promise as a method for extending specialist coverage. Future research is needed in this important area.

Acknowledgments

Potential conflicts of interest. All authors have no relevant conflicts of interest.

  • ©2017 by the North Carolina Institute of Medicine and The Duke Endowment. All rights reserved.

References

  1. ↵
    1. Meyer RE,
    2. Herrick H
    Prevalence of diabetes-related eye disease in North Carolina: findings from the North Carolina Behavioral Risk Factor Surveillance System. N C Med J. 2011;72(5):413-416.
    OpenUrlPubMed
  2. ↵
    Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology. 1991;98(5 Suppl):766-785.
    OpenUrlCrossRefPubMed
    1. Wells JA,
    2. Glassman AR,
    3. Ayala AR, et al.
    Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema: two-year results from a comparative effectiveness randomized clinical trial. Ophthalmology. 2016;123(6):1351-1359.
    OpenUrl
  3. ↵
    1. Writing Committee for the Diabetic Retinopathy Clinical Research Network,
    2. Gross JG,
    3. Glassman AR, et al.
    Panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy: a randomized clinical trial. JAMA. 2015;314(20):2137-2146.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Scanlon PH
    The English national screening programme for sight-threatening diabetic retinopathy. J Med Screen. 2008;15(1):1-4.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Gibson DM
    Diabetic retinopathy and age-related macular degeneration in the U.S. Am J Prev Med. 2012;43(1):48-54.
    OpenUrlCrossRefPubMed
  6. ↵
    1. American Academy of Opthalmology
    Diabetic Retinopathy PPP - Updated 2016. American Academy of Ophthalmology website. http://www.aao.org/preferred-practice-pattern/diabetic-retinopathy-ppp-updated-2016. Published February 24, 2016. Accessed October 16, 2016.
  7. ↵
    1. Garg S,
    2. Jani PD,
    3. Kshirsagar AV,
    4. King B,
    5. Chaum E
    Telemedicine and retinal imaging for improving diabetic retinopathy evaluation. Arch Intern Med. 2012;172(21):1677-1678.
    OpenUrlCrossRefPubMed
  8. ↵
    1. Lin DY,
    2. Blumenkranz MS,
    3. Brothers RJ,
    4. Grosvenor DM
    The sensitivity and specificity of single-field nonmydriatic monochromatic digital fundus photography with remote image interpretation for diabetic retinopathy screening: a comparison with ophthalmoscopy and standardized mydriatic color photography. Am J Ophthalmol. 2002;134(2):204-213.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Owsley C,
    2. McGwin G Jr..,
    3. Lee DJ, et al.
    Diabetes eye screening in urban settings serving minority populations: detection of diabetic retinopathy and other ocular findings using telemedicine. JAMA Ophthalmol. 2015;133(2):174-181.
    OpenUrl
  10. ↵
    1. Gibson DM
    Eye care availability and access among individuals with diabetes, diabetic retinopathy, or age-related macular degeneration. JAMA Ophthalmol. 2014;132(4):471-477.
    OpenUrl
  11. ↵
    1. Taylor CR,
    2. Merin LM,
    3. Salunga AM, et al.
    Improving diabetic retinopathy screening ratios using telemedicine-based digital retinal imaging technology: the Vine Hill study. Diabetes Care. 2007;30(3):574-578.
    OpenUrlAbstract/FREE Full Text
  12. ↵
    1. Zhang X,
    2. Norris SL,
    3. Saadine J, et al.
    Effectiveness of interventions to promote screening for diabetic retinopathy. Am J Prev Med. 2007;33(4):318-335.
    OpenUrlCrossRefPubMed
  13. ↵
    1. Keenum Z,
    2. McGwin G Jr..,
    3. Witherspoon CD,
    4. Haller JA,
    5. Clark ME,
    6. Owsley C
    Patients' adherence to recommended follow-up eye care after diabetic retinopathy screening in a publicly funded county clinic and factors associated with follow-up eye care use. JAMA Ophthalmol. 2016;134(11):1221-1228.
    OpenUrl
  14. ↵
    1. Basch CE,
    2. Walker EA,
    3. Howard CJ,
    4. Shamoon H,
    5. Zybert P
    The effect of health education on the rate of ophthalmic examinations among African Americans with diabetes mellitus. Am J Public Health. 1999;89(12):1878-1882.
    OpenUrlCrossRefPubMed
  15. ↵
    1. Threatt J,
    2. Williamson JF,
    3. Huynh K,
    4. Davis RM
    Ocular disease, knowledge and technology applications in patients with diabetes. Am J Med Sci. 2013;345(4):266-270.
    OpenUrlCrossRefPubMed
  16. ↵
    1. Davis RM,
    2. Hitch AD,
    3. Salaam MM,
    4. Herman WH,
    5. Zimmer-Galler IE,
    6. Mayer-Davis EJ
    TeleHealth improves diabetes self-management in an underserved community: Diabetes TeleCare. Diabetes Care. 2010;33(8):1712-1717.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

North Carolina Medical Journal: 78 (2)
North Carolina Medical Journal
Vol. 78, Issue 2
March-April 2017
  • Table of Contents
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on North Carolina Medical Journal.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Screening for Diabetic Retinopathy
(Your Name) has sent you a message from North Carolina Medical Journal
(Your Name) thought you would like to see the North Carolina Medical Journal web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
10 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Screening for Diabetic Retinopathy
Julie B. Skaggs, Xinxin Zhang, Daniel J. Olson, Seema Garg, Richard M. Davis
North Carolina Medical Journal Mar 2017, 78 (2) 121-123; DOI: 10.18043/ncm.78.2.121

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Screening for Diabetic Retinopathy
Julie B. Skaggs, Xinxin Zhang, Daniel J. Olson, Seema Garg, Richard M. Davis
North Carolina Medical Journal Mar 2017, 78 (2) 121-123; DOI: 10.18043/ncm.78.2.121
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Background
    • Current Guidelines
    • Disparities
    • Focus for Research
    • Patient Retention and Education
    • Current Research
    • Conclusion
    • Acknowledgments
    • References
  • Info & Metrics
  • References
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Perceived facilitators and barriers to chronic disease management in primary care networks of Singapore: a qualitative study
  • Trends and Racial/Ethnic Disparities in Diabetic Retinopathy Among Adults with Diagnosed Diabetes in North Carolina, 2000-2015
  • Introduction to The NCMJ's Special Issue on Vision and Hearing Loss
  • Google Scholar

More in this TOC Section

Policy Forum

  • From Here to There—With a Spring in Our Steps
  • Listening to the Stories of a Storied People
  • Can the Front Line Hold?
Show more Policy Forum

INVITED COMMENTARIES AND SIDEBARS

  • Sidebar: Community-driven Approaches to Preventing Overdoses Among American Indians
  • Sidebar: History Shaping the Future: How History Influences Health in North Carolina Native American Communities
  • Sidebar: Impact of Racial Misclassification of Health Data on American Indians in North Carolina
Show more INVITED COMMENTARIES AND SIDEBARS

Similar Articles

About & Contact

  • About the NCMJ
  • Editorial Board
  • Feedback

Info for

  • Advertisers
  • Authors
  • Reviewers
  • Subscribers

Articles & Alerts

  • Archive
  • Current Issue
  • Get Alerts
  • Upcoming Articles

Additional Content

  • Current NCIOM Task Forces
  • NC Health Data & Resources
  • NCIOM Blog
North Carolina Medical Journal

ISSN: 0029-2559

© 2022 North Carolina Medical Journal

Powered by HighWire